The study aims to (a) identify future trachoma mapping needs in the Pacific and (b) to examine whether any temporal trends in trachoma prevalence could be ascertained from the historical literature on trachoma in the Pacific Islands.
Height and age-based dosing for Zithromax POS and tablets in Arabic as at July 2018
Key messages for the WHO Eastern Mediterranean Region from the 2018 GET2020 database as at 17 April 2018
This document presents (i) the principles important to the design of trachoma prevalence surveys conducted after interventions intended to eliminate the disease as a public health problem, and (ii) WHO recommendations for their implementation.
This article looks at the contribution of Helen Keller International and its work to build the capacity of Ministries of Health to conduct community mobilization, mass drug administration campaigns, morbidity management, monitoring and evaluation for neglected tropical diseases.
This study explores the relationship between TF and PCR throughout an elimination program and a sero-catalytic model to evaluate the utility of two cross-sectional sero-surveys for estimating sero-conversion rates.
This study assessed several methods for identifying a core group for trachoma, assuming varying degrees of knowledge about the transmission process.
This systematic review synthesises evidence on the emergence of antimicrobial resistance after mass azithromycin distribution.
In a trachoma hyperendemic region, a TF prevalence <5% was successfully maintained in five districts for ≥2 years after stopping MDA. MDA is still not warranted for these districts, however, the S, F and E components of the SAFE strategy should continue.